Eli Lilly (LLY) PT Raised to $106 at Societe Generale
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Eli Lilly (LLY) PT Lowered to $124 at BMO Capital
November 7, 2018 12:40 PM ESTBMO Capital analyst Alex Arfaei lowered the price target on Eli Lilly (NYSE: LLY) to $124.00 (from $130.00) while maintaining an Outperform rating.
The analyst comments, "Lilly had a mixed, incrementally negative 3Q18, but our thesis is unchanged. Although price pressure in the... More
